Biopharmaceutical company Mind Medicine announced March 7 that the FDA has awarded "breakthrough therapy" status to its trial of patients using MM120 (lysergide D-tartrate) to treat anxiety.

About MM120 Orally Disintegrating Tablet (ODT) MM120 ODT (lysergide D-tartrate or LSD) is a synthetic ergotamine belonging to the group of classic, or serotonergic, psychedelics which acts as a ...

Voyage is the first-ever Phase 3 study of lysergide D-tartrate (LSD) with the primary endpoint measuring the change from baseline in the Hamilton Anxiety Rating Scale (HAM-A) score at week 12 for ...